Sub-clearance treatment to slow malaria drug resistance?

Trends in Parasitology

Volumn 27, Issue 2, 2011, Pages 50-51

  Goncalves, Bronner P A ^a   Paul, Richard E L ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ECOLOGY; GENOTYPE; HEALTH CARE; LETTER; MALARIA; MALARIA FALCIPARUM; NONHUMAN; PUBLIC HEALTH;

ANTIMALARIALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE; GENOTYPE; HOST-PARASITE INTERACTIONS; HUMANS; MALARIA, FALCIPARUM;

EID: 79251599954     PISSN: 14714922     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pt.2010.10.001     Document Type: Letter

References (12)

1. Huijben. S. et al. (2010) Chemotherapy, within-host ecology and the fitness of drug-resistant malaria parasites. Evolution doi:10.1111/j.1558-5646.2010.01068.x.
2. Koella, J.C. and Antia, R. (2003) Epidemiological models for the spread of anti-malarial resistance. Malaria J. doi:10.1186/1475-2875r-r2-3.
3. Hastings I.M. Complex dynamics and stability of resistance to antimalarial drugs. Parasitology 2006, 132:615-624.
4. Wargo A.R., et al. Competitive release and facilitation of drug-resistant parasites after therapeutic chemotherapy in a rodent malaria model. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:19914-19919.
5. Read A.F., Huijben S. Evolutionary biology and the avoidance of antimicrobial resistance. Evol. Appl. 2009, 2:40-51.
6. Ord R., et al. Seasonal carriage of pfcrt and pfmdr1 alleles in Gambian Plasmodium falciparum imply reduced fitness of chloroquine-resistant parasites. J. Infect. Dis. 2007, 196:1613-1619.
7. Harrington W.E., et al. Competitive facilitation of drug resistant Plasmodium falciparum malaria parasites in pregnant women who receive preventive treatment. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:9027-9032.
8. Hastings I.M., et al. The evolution of drug-resistant malaria: the role of drug elimination half-life. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2002, 357:505-519.
9. Yeung S., et al. Antimalarial drug resistance, artemisinin-based combination therapy, and the contribution of modeling to elucidating policy choices. Am. J. Trop. Med. Hyg. 2004, 71(Suppl. 2):179-286.
10. Pongtavornpinyo, W. et al. (2008) Spread of anti-malarial drug resistance: mathematical model with implications for ACT drug policies. Malaria J. doi:10.1186/1475-2875r-r7-229.
11. Débarre F., et al. Evolutionary epidemiology of drug-resistance in space. PLoS Comput. Biol. 2009, 5:e1000337.
12. Hastings I.M., Watkins W.M. Tolerance is the key to understanding antimalarial drug resistance. Trends Parasitol. 2006, 22:71-77.